摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-{5-[(Pyrrolidin-1-yl)methyl]-1,2,4-oxadiazol-3-yl}aniline | 89250-41-9

中文名称
——
中文别名
——
英文名称
3-{5-[(Pyrrolidin-1-yl)methyl]-1,2,4-oxadiazol-3-yl}aniline
英文别名
3-[5-(pyrrolidin-1-ylmethyl)-1,2,4-oxadiazol-3-yl]aniline
3-{5-[(Pyrrolidin-1-yl)methyl]-1,2,4-oxadiazol-3-yl}aniline化学式
CAS
89250-41-9
化学式
C13H16N4O
mdl
——
分子量
244.29
InChiKey
MTXPAXXQCPGINT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    68.2
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Substituted heterocyclyl phenylformamidines, processes for their preparation and their pharmaceutical use
    申请人:ISTITUTO DE ANGELI S.p.A.
    公开号:EP0094727A2
    公开(公告)日:1983-11-23
    Object of the present invention are new pharmacologically active substituted heterocyclylphenylformamidines of formula in which A represents a hydrogen atom, an amino group which may be substituted by one or two alkyl groups having 1 to 3 carbon atoms or a saturated heterocyclic ring, R represents a hydrogen atom or a methyl group, R1 represents a linear or branched alkyl group which may contain 1 or 2 heteroatoms such as a sulfur, an oxygen or nitrogen atom or may form a substituted or an unsubstituted cyclic ring, an alkenyl group, an alkynyl group, a cycloalkyl group or a phenyl group, R2 and R3 which may be the same or different, represent a hydrogen atom, an alkyl or alkoxy group having 1 to 3 carbon atom or a halogen atom, m and n represent 0 or 1, Het represents a substituted or unsubstituted heterocyclic ring containing from 1 to 3 heteroatoms (except the imidazole ring when R1 is a linear or branched alkyl group not containing heteroatoms and R2 and R3 are both hydrogen atoms), tautomers thereof and acid addition salts of the aforesaid compounds. Processes for preparation of the compounds of formula (I) and their intermediates as well as pharmaceutical compositions containing them are also object of this invention. The new compounds are H2-receptor blocking agents, inhibit gastric acid secretion, and are useful antiulcer agents.
    本发明的目的是具有药理活性的新的取代杂环苯基甲脒,其式为 其中 A 代表氢原子、可被一个或两个具有 1 至 3 个碳原子的烷基或饱和杂环取代的基,R 代表氢原子或甲基,R1 代表直链或支链烷基,该烷基可含有 1 或 2 个杂原子,如原子、氧原子或氮原子,或可形成取代或未取代的环环、烯基、炔基、环烷基或苯基、R2和R3可以相同或不同,代表氢原子、具有1至3个碳原子的烷基或烷氧基或卤素原子,m和n代表0或1,Het代表含有1至3个杂原子的取代或未取代的杂环(当R1为不含杂原子的直链或支链烷基且R2和R3均为氢原子时,咪唑环除外)、其同系物以及上述化合物的酸加成盐。制备式(I)化合物及其中间体以及含有它们的药物组合物的工艺也是本发明的目的。 新化合物是 H2 受体阻断剂,可抑制胃酸分泌,是有效的抗溃疡剂。
查看更多